Initiation, response assessment, and switch of antibody therapies in patients with severe asthma – A survey among German specialists

BACKGROUND: For therapy of severe asthma 5 monoclonal antibodies have been available in Germany up to November 2022, but no clear rules exist on choice of initial therapy, assessment of response, and switch. OBJECTIVE: To assess current practice on all aspects of biologic therapy by specialists in G...

Descripción completa

Detalles Bibliográficos
Autores principales: Suhling, Hendrik, Skowasch, Dirk, Bergmann, Karl-Christian, Mümmler, Carlo, Buhl, Roland, Ehmann, Rainer, Hamelmann, Eckard, Idzko, Marco, Margret Jandl, Schulz, Christian, Schmidt, Olaf, Taube, Christian, Korn, Stephanie, Milger, Katrin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: World Allergy Organization 2023
Materias:
Full Length Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10682826/
https://www.ncbi.nlm.nih.gov/pubmed/38033455
http://dx.doi.org/10.1016/j.waojou.2023.100844

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10682826/
https://www.ncbi.nlm.nih.gov/pubmed/38033455
http://dx.doi.org/10.1016/j.waojou.2023.100844

Ejemplares similares